Publicação

Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

Ver documento

Detalhes bibliográficos
Resumo:Hemolytic uremic syndromes (HUSs) are a heterogeneous group of conditions, only some of which are mediated by complement (complement-mediated HUS). We report the outcome of the 2023 International Society of Nephrology HUS International Forum where a global panel of experts considered the current state of the art, identified areas of uncertainty, and proposed optimal solutions. Areas of uncertainty and areas for future research included the nomenclature of HUS, novel complement testing strategies, identification of biomarkers, genetic predisposition to atypical HUS, optimal dosing and withdrawal strategies for C5 inhibitors, treatment of kidney transplant recipients, disparity of access to treatment, and the next generation of complement inhibitors in complement-mediated HUS. The current rationale for optimal patient management is described.
Autores principais:Kavanagh, David
Outros Autores:Ardissino, Gianluigi; Brocklebank, Vicky; Bouwmeester, Romy N.; Bagga, Arvind; ter Heine, Rob; Johnson, Sally; Licht, Christoph; Ma, Alison L.T.; Noris, Marina; Praga, Manuel; Rondeau, Eric; Sinha, Aditi; Smith, Richard J.H.; Sheerin, Neil S.; Trimarchi, H.; Wetzels, Jack F.M.; Vivarelli, Marina; Van de Kar, Nicole C.A.J.; Greenbaum, Larry A.; Lungu, Adrian Catalin; Żurowska, Aleksandra; Gerogianni, Alexandra; Durkan, Anne; Schijvens, Anne; Lapeyraque, Anne Laure; Java, Anuja; Awan, Atif; Covella, Bianca; Dixon, Brad; El Sissy, Carine; Duinevel, Caroline; Maville, Christine; Turudic, Daniel; Karpman, Diana; Haffner, Dieter; Trembecka-Dubel, Elżbieta; Ozaltin, Fatih; Emma, Francesco; Schaefer, Franz; Kang, Hee Gyung; Trimarchi, Hernán; Trujillo, Hernando; Ulasi, Ifeoma; Ekwueme, Alex; Menne, Jan; Laurence, Jeffrey; Calado, Joaquim; Hofer, Johannes; Zuber, Julien
Assunto:acute kidney injury C5 complement hemolytic uremic syndrome thrombotic microangiopathy Nephrology
Ano:2024
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
Descrição
Resumo:Hemolytic uremic syndromes (HUSs) are a heterogeneous group of conditions, only some of which are mediated by complement (complement-mediated HUS). We report the outcome of the 2023 International Society of Nephrology HUS International Forum where a global panel of experts considered the current state of the art, identified areas of uncertainty, and proposed optimal solutions. Areas of uncertainty and areas for future research included the nomenclature of HUS, novel complement testing strategies, identification of biomarkers, genetic predisposition to atypical HUS, optimal dosing and withdrawal strategies for C5 inhibitors, treatment of kidney transplant recipients, disparity of access to treatment, and the next generation of complement inhibitors in complement-mediated HUS. The current rationale for optimal patient management is described.